BR112012000530A2 - uso de uma população de nanopartículas metálicas, e, composição farmacêutica. - Google Patents
uso de uma população de nanopartículas metálicas, e, composição farmacêutica.Info
- Publication number
- BR112012000530A2 BR112012000530A2 BR112012000530A BR112012000530A BR112012000530A2 BR 112012000530 A2 BR112012000530 A2 BR 112012000530A2 BR 112012000530 A BR112012000530 A BR 112012000530A BR 112012000530 A BR112012000530 A BR 112012000530A BR 112012000530 A2 BR112012000530 A2 BR 112012000530A2
- Authority
- BR
- Brazil
- Prior art keywords
- population
- pharmaceutical composition
- metallic nanoparticles
- nanoparticles
- metallic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122019025997A BR122019025997B8 (pt) | 2009-07-10 | 2010-07-09 | uso de uma população de nanopartículas metálicas |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22457609P | 2009-07-10 | 2009-07-10 | |
EP09165157A EP2275137A1 (en) | 2009-07-10 | 2009-07-10 | Metallic nanoparticles, preparation and uses thereof |
EP09165157.0 | 2009-07-10 | ||
US61/224,576 | 2009-07-10 | ||
PCT/EP2010/059871 WO2011003999A1 (en) | 2009-07-10 | 2010-07-09 | Metallic nanoparticles, preparation and uses thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
BR112012000530A2 true BR112012000530A2 (pt) | 2016-11-16 |
BR112012000530A8 BR112012000530A8 (pt) | 2017-12-26 |
BR112012000530B1 BR112012000530B1 (pt) | 2021-01-19 |
BR112012000530B8 BR112012000530B8 (pt) | 2021-05-25 |
Family
ID=41110399
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012000530A BR112012000530B8 (pt) | 2009-07-10 | 2010-07-09 | uso de uma população de nanopartículas de ouro, e, composição farmacêutica |
BR122019025997A BR122019025997B8 (pt) | 2009-07-10 | 2010-07-09 | uso de uma população de nanopartículas metálicas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122019025997A BR122019025997B8 (pt) | 2009-07-10 | 2010-07-09 | uso de uma população de nanopartículas metálicas |
Country Status (25)
Country | Link |
---|---|
US (2) | US9700621B2 (pt) |
EP (3) | EP2275137A1 (pt) |
JP (1) | JP5739883B2 (pt) |
KR (1) | KR101670757B1 (pt) |
CN (1) | CN102470173B (pt) |
AU (1) | AU2010270225B2 (pt) |
BR (2) | BR112012000530B8 (pt) |
CA (1) | CA2765290C (pt) |
CY (1) | CY1118600T1 (pt) |
DK (2) | DK3178494T3 (pt) |
EA (1) | EA020942B1 (pt) |
ES (2) | ES2837412T3 (pt) |
HR (2) | HRP20170175T1 (pt) |
HU (2) | HUE031796T2 (pt) |
IL (1) | IL217287A (pt) |
LT (1) | LT2451481T (pt) |
MA (1) | MA33516B1 (pt) |
MX (2) | MX347606B (pt) |
NZ (1) | NZ597564A (pt) |
PL (2) | PL2451481T3 (pt) |
PT (2) | PT3178494T (pt) |
SG (2) | SG177611A1 (pt) |
SI (1) | SI2451481T1 (pt) |
WO (1) | WO2011003999A1 (pt) |
ZA (1) | ZA201200902B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102051248B1 (ko) | 2009-07-08 | 2019-12-02 | 클레네 나노메디슨, 인크. | 의학적 치료를 위한 신규한 금계 나노결정 및 이를 위한 전기화학 제조 방법 |
EP2275137A1 (en) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
US20120190979A1 (en) | 2011-01-24 | 2012-07-26 | Actium BioSystems, LLC | System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents |
KR102069907B1 (ko) * | 2011-08-26 | 2020-01-23 | 엔도마그네틱스 엘티디 | 체강 및 공동형 부위에 있는 암을 치료하기 위한 에너지 필드 발생 장치 |
AU2012351537B2 (en) | 2011-12-16 | 2017-03-02 | Nanobiotix | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
US10098952B2 (en) * | 2013-01-25 | 2018-10-16 | Nanobiotix | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer |
JP6387400B2 (ja) * | 2013-05-30 | 2018-09-05 | ナノビオティックスNanobiotix | 医薬組成物、その製造および使用 |
WO2014202723A1 (en) * | 2013-06-20 | 2014-12-24 | Nanobiotix | Compositions and methods for use in medical diagnosis |
TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
JP6778371B2 (ja) * | 2015-01-23 | 2020-11-04 | ミヨシ油脂株式会社 | 金微粒子マトリックスメタロプロテアーゼ阻害剤 |
WO2016189125A1 (en) | 2015-05-28 | 2016-12-01 | Nanobiotix | Nanoparticles for use as a therapeutic vaccine |
DE102017101057A1 (de) * | 2017-01-20 | 2018-07-26 | Fraunhofer-Institut für Angewandte Polymerforschung IAP | Zwitterionische Nanopartikel |
JP7376901B2 (ja) * | 2017-11-13 | 2023-11-09 | 国立大学法人北海道大学 | 修飾金属ナノ粒子及び医薬組成物 |
CN110883341B (zh) * | 2018-09-11 | 2021-03-30 | 清华大学 | 金纳米团簇制备方法 |
WO2021060498A1 (ja) * | 2019-09-27 | 2021-04-01 | 国立大学法人京都大学 | 多孔性シリカを含むナノ粒子およびその製造方法、ならびに放射線治療用医薬組成物 |
EP4157457A1 (en) * | 2020-05-26 | 2023-04-05 | Nanobiotix | Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000006244A2 (en) * | 1998-07-30 | 2000-02-10 | Hainfeld James F | Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
US20070031337A1 (en) * | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
DE102007040934A1 (de) | 2007-08-30 | 2009-03-05 | Man Diesel A/S | Verfahren und Vorrichtung zur Reinigung von Abgas |
EP2130553A1 (en) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
EP2275137A1 (en) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
-
2009
- 2009-07-10 EP EP09165157A patent/EP2275137A1/en not_active Withdrawn
-
2010
- 2010-07-09 BR BR112012000530A patent/BR112012000530B8/pt not_active IP Right Cessation
- 2010-07-09 ES ES17152585T patent/ES2837412T3/es active Active
- 2010-07-09 HU HUE10729917A patent/HUE031796T2/en unknown
- 2010-07-09 CA CA2765290A patent/CA2765290C/en active Active
- 2010-07-09 JP JP2012519006A patent/JP5739883B2/ja active Active
- 2010-07-09 LT LTEP10729917.4T patent/LT2451481T/lt unknown
- 2010-07-09 EA EA201270154A patent/EA020942B1/ru not_active IP Right Cessation
- 2010-07-09 MX MX2015010613A patent/MX347606B/es unknown
- 2010-07-09 US US13/383,049 patent/US9700621B2/en active Active
- 2010-07-09 SI SI201031410A patent/SI2451481T1/sl unknown
- 2010-07-09 PT PT171525850T patent/PT3178494T/pt unknown
- 2010-07-09 DK DK17152585.0T patent/DK3178494T3/da active
- 2010-07-09 AU AU2010270225A patent/AU2010270225B2/en not_active Ceased
- 2010-07-09 WO PCT/EP2010/059871 patent/WO2011003999A1/en active Application Filing
- 2010-07-09 KR KR1020127003701A patent/KR101670757B1/ko active IP Right Grant
- 2010-07-09 PT PT107299174T patent/PT2451481T/pt unknown
- 2010-07-09 DK DK10729917.4T patent/DK2451481T3/en active
- 2010-07-09 EP EP10729917.4A patent/EP2451481B1/en active Active
- 2010-07-09 PL PL10729917T patent/PL2451481T3/pl unknown
- 2010-07-09 ES ES10729917.4T patent/ES2616628T3/es active Active
- 2010-07-09 SG SG2012002044A patent/SG177611A1/en unknown
- 2010-07-09 CN CN201080031148.1A patent/CN102470173B/zh active Active
- 2010-07-09 HU HUE17152585A patent/HUE052686T2/hu unknown
- 2010-07-09 NZ NZ597564A patent/NZ597564A/xx not_active IP Right Cessation
- 2010-07-09 SG SG10201403832YA patent/SG10201403832YA/en unknown
- 2010-07-09 PL PL17152585T patent/PL3178494T3/pl unknown
- 2010-07-09 EP EP17152585.0A patent/EP3178494B1/en active Active
- 2010-07-09 MX MX2012000285A patent/MX2012000285A/es active IP Right Grant
- 2010-07-09 BR BR122019025997A patent/BR122019025997B8/pt not_active IP Right Cessation
-
2011
- 2011-12-29 IL IL217287A patent/IL217287A/en active IP Right Grant
-
2012
- 2012-02-07 ZA ZA2012/00902A patent/ZA201200902B/en unknown
- 2012-02-08 MA MA34614A patent/MA33516B1/fr unknown
-
2017
- 2017-02-02 HR HRP20170175TT patent/HRP20170175T1/hr unknown
- 2017-02-07 CY CY20171100166T patent/CY1118600T1/el unknown
- 2017-06-28 US US15/635,252 patent/US10391174B2/en active Active
-
2020
- 2020-12-15 HR HRP20202005TT patent/HRP20202005T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012000530A8 (pt) | uso de uma população de nanopartículas metálicas, e, composição farmacêutica. | |
BRPI1010768A2 (pt) | composto, e, composição farmacêutica. | |
BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
BRPI1014316A2 (pt) | composição, e, uso de uma composição | |
BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BR112012002331A2 (pt) | composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica | |
BRPI0908792A2 (pt) | Composição, e, uso de uma combinação | |
BR112013003536A2 (pt) | composição, e utilização de uma composição. | |
BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
BRPI1009757A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
BRPI0914793A2 (pt) | Composição, e, uso de uma composição | |
BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
BRPI1016194A2 (pt) | Composição inseticida que compreende uma espinosina e um óxido de metal. | |
BRPI1012250A2 (pt) | composição lubrificante, e, uso de uma composição lubrificante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2730 DE 02-05-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |